A Genetically Defined Model for Human Ovarian Cancer

Jinsong Liu, Gong Yang, Jennifer A. Thompson-Lanza, Armand Glassman, Kimberly Hayes, Andrea Patterson, Rebecca T. Marquez, Nelly Auersperg, Yinhua Yu, William C. Hahn, Gordon B. Mills, Robert C. Bast

    Research output: Contribution to journalArticlepeer-review

    223 Scopus citations

    Abstract

    Disruptions of the p53, retinoblastoma (Rb), and RAS signaling pathways and activation of human telomerase reverse transcriptase (hTERT) are common in human ovarian cancer; however, their precise role in ovarian cancer development is not clear. We thus introduced the catalytic subunit of hTERT, the SV40 early genomic region, and the oncogenic alleles of human HRAS or KRAS into human ovarian surface epithelial cells and examined the phenotype and gene expression profile of those cells. Disruption of p53 and Rb pathway by SV40 early genomic region and hTERT immortalized but did not transform the cells. Introduction of HRASV12 of KRASV12 into the immortalized cells, however, allowed them to form s.c. tumors after injection into immunocompromised mice. Peritoneal injection of the transformed cells produced undifferentiated carcinoma or malignant mixed Mullerian tumor and developed ascites; the tumor cells are focally positive for CA125 and mesothelin. Gene expression profile analysis of transformed cells revealed elevated expression of several cytokines, including interleukin (IL)-1β, IL-6, and IL-8, that are up-regulated by the nuclear factor-κB pathway, which is known to contribute to the tumor growth of naturally ovarian cancer cells. Incubation with antibodies to IL-1β or IL-8 led to apoptosis in the ras-transformed cells and ovarian cancer cells but not in immortalized cells that had not been transformed. Thus, the transformed human ovarian surface epithelial cells recapitulated many features of natural ovarian cancer including a subtype of ovarian cancer histology, formation of ascites, CA125 expression, and nuclear factor-κB-mediated cytokine activation. These cells provide a novel model system to study human ovarian cancer.

    Original languageEnglish (US)
    Pages (from-to)1655-1663
    Number of pages9
    JournalCancer Research
    Volume64
    Issue number5
    DOIs
    StatePublished - Mar 1 2004

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'A Genetically Defined Model for Human Ovarian Cancer'. Together they form a unique fingerprint.

    Cite this